Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
64.67
+1.41 (2.23%)
Jul 23, 2025, 10:44 AM - Market open
Merus Employees
As of December 31, 2024, Merus had 321 total employees, including 260 full-time and 61 part-time employees. The number of employees increased by 92 or 40.17% compared to the previous year.
Employees
321
Change (1Y)
92
Growth (1Y)
40.17%
Revenue / Employee
$170,505
Profits / Employee
-$864,000
Market Cap
4.82B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
MRUS News
- 20 days ago - One of Finland's largest energy storage facilities commissioned in Lappeenranta – Merus Power's EUR 15 million delivery completed - GlobeNewsWire
- 6 weeks ago - Bicara Therapeutics Looks To Reclaim Some Of The Spotlight From Merus - Seeking Alpha
- 7 weeks ago - Merus N.V. Announces Pricing of Public Offering of Common Shares - GlobeNewsWire
- 7 weeks ago - Merus N.V. Announces Proposed Public Offering of Common Shares - GlobeNewsWire
- 2 months ago - Merus to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Merus' Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC - GlobeNewsWire
- 2 months ago - Merus Announces the Journal Publication of Petosemtamab Mechanism of Action - GlobeNewsWire
- 2 months ago - Merus to Present at BofA Securities 2025 Health Care Conference - GlobeNewsWire